Skip to content
Open access

SAP loss limits anti-insulin atypical B cell activation and pro-inflammatory CD8 T cells despite preserved Tfh responses to protect against type 1 diabetes

Aug 2026 · bioRxiv · 0 citations
Biology Medicine

TL;DR

The essential role of SAP in mediating proinflammatory, anti-insulin B-T interactions to support T1D is highlighted, which led to reduced pro-inflammatory CD8+ T cell formation and islet-reactive progenitor exhausted CD8+ T cells in pancreata.

Abstract

SLAM-associated protein (SAP) is required for T follicular helper (Tfh)-B cell interactions that underlie germinal center formation, but it is unclear if SAP governs islet-reactive CD4+ T cell-B cell interactions and downstream pro-inflammatory CD8+ T cell destruction of islets in type 1 diabetes (T1D). To address this question, we utilized the VH125SD.NOD mouse model, whereby 1-3% of all B cells bind insulin. Germline SAP loss in this model led to reduced T1D incidence and impaired germinal center B cell formation, yet did not alter T follicular helper cell formation or phenotype. SAP loss reduced pro-inflammatory and activated insulin-autoreactive B-T interactions and limited anti-insulin B cell proliferation, activation, and upregulation of co-stimulatory molecules otherwise enhanced in the pancreas. Anti-insulin extrafollicular antibody and memory responses following immunization were preserved in VH125SD.SAP-/-.NOD mice, but activated atypical anti-insulin B cell responses were reduced. Ultimately, SAP loss led to reduced pro-inflammatory CD8+ T cell formation and islet-reactive progenitor exhausted CD8+ T cells in pancreata. These data highlight the essential role of SAP in mediating proinflammatory, anti-insulin B-T interactions to support T1D. Graphical Abstract

Read PDF

Similar papers

Open access Oct 2026

Transcriptionally distinct atypical B cell populations contribute to insulin autoreactivity and show differential activation, isotype switching, and somatic hypermutation in early-stage type 1 diabetes individuals

Autoreactive B cells must escape immune tolerance mechanisms to drive autoimmune disease, potentially through alternative paths to memory and antibody-secreting cell formation. “Atypical” B cells represent one such alternative pathway and are expanded in several human autoimmune diseases. Atypical B cells display pheno...

Lindsay E. Bass, Landon M. Clark, Bryan Han et al. · 0 citations
Aug 2026

Donor-specific antibodies enhance inflammatory immune remodeling associated with TAK1/NF-κB and IL-6/STAT3 signaling in a liver transplantation-related co-culture model.

Antibody-mediated rejection (AMR) after liver transplantation remains underrecognized, and how donor-specific antibodies (DSAs) amplify inflammation within the liver immune microenvironment remains unclear. We generated DSA-positive serum in Lewis rats through Brown Norway splenocyte infusion and skin-allograft presens...

Bo Luo, Yuan-Yi Mang, Guo-Yu Chen et al. · 0 citations
Open access Oct 2026

Type 1 diabetes SIRPG risk variants increase SIRPγ expression and CD47 loss enhances CD8+ T cell cytotoxicity

Type 1 diabetes (T1D) risk variants within SIRPG influence transcript splicing and alter the expression of signal regulatory protein gamma (SIRPγ) on human T cells; however, the functional consequences of the risk variants remain poorly defined. Here, we demonstrate that peripheral blood mononuclear cells from individu...

Robert C. Sharp, Matthew E. Brown, Leeana D. Peters et al. · 0 citations
Review Open access Sep 2026

ApoB-specific CD4+ T cells in atherosclerosis: MHC-II antigen presentation, T cell plasticity, and immune tolerance

Despite intensive lipid-lowering therapy, substantial residual cardiovascular risk persists, and antigen-specific adaptive immunity may contribute to the inflammatory burden that remains after lipid levels are controlled. Apolipoprotein B (ApoB)-containing lipoproteins accumulate in the arterial wall and undergo local...

Xiao-Bo Cao, Chong-Jing Mu, Yi Xu · 0 citations
Open access Sep 2026

Engineering the insulin signal peptide to protect human pancreatic beta cells from autoimmune destruction.

Autoreactive T cells that destroy beta cells in type 1 diabetes are largely targeting insulin signal peptide fragments. HLA knockout beta-cells have been proposed to create hypo-immune cells, but this strategy poses significant tumorigenic risks. Alternatively, we hypothesized that insulin signal peptide modification w...

Farah Kobaisi, Masaya Oshima, Zhi-Cheng Zhou et al. · 0 citations
Open access Aug 2026

PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus (JCPyV). PD-1 checkpoint immunotherapy has benefited some PML patients, but reasons for its variable outcomes are unclear. Usi...

Arrienne B. Butic, E. Afanasiev, Samantha A. Spencer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.